Mack Roszell III 4

What Happened Mack Roszell III, a director of Sanara MedTech Inc. (SMTI), was granted 5,308 restricted shares on June 4, 2026. The shares were awarded (code A) at $0.00 per share (no cash paid). This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: June 4, 2026; Form 4 filed June 5, 2026 (timely filing).
• Security: Common stock — 5,308 restricted shares; reported acquisition price $0.00 (award).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The shares were granted under the Sanara MedTech 2024 Omnibus Long‑Term Incentive Plan and vest on the earlier of the 2027 annual shareholder meeting or June 4, 2027, provided Roszell remains providing certain services through that date.
• Transaction type: Award/Grant (compensation), not a purchase (code A).

Context Restricted stock awards like this are common for directors and are typically part of ongoing compensation or retention programs. Because these are time‑vesting awards (subject to continued service), they do not necessarily indicate immediate market sentiment or insider buying interest.